학술논문

LBA67 A phase III, randomized study of atezolizumab plus bevacizumab and chemotherapy in patients with EGFR or ALK mutated in non-small cell lung cancer (ATTLAS, KCSG-LU19-04)
Document Type
Abstract
Source
In Annals of Oncology October 2023 34 Supplement 2:S1311-S1311
Subject
Language
ISSN
0923-7534